| |
|
|
|
CASI Pharmaceuticals- Inc.  
|
|
7.04 -0.17 (-0.02%) |
07-19 14:41 |
|
Open: |
7.2 |
Pre close: |
7.21 |
Target:
|
9.81
|
|
High: |
7.3 |
Low: |
6.92 |
Resistance:
|
8.40
9.81
|
|
Volume: |
294,136 |
Market Cap: |
606M |
Support:
|
6.40
5.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.28
 |
MACD |
MACD(12,26):
|
0.18 |
|
MA(20): |
7.26  |
Signal(12,26,9): |
0.23 |
|
MA(100): |
6.12 |
Stochastic Oscillator |
%K(14,3):
|
34.52 |
|
MA(250): |
3.95 |
%D(3): |
49.14 |
|
Average Volume(K) |
3-Month: |
68935
|
52-Week |
High:
|
8.42 |
|
10-Days: |
41487 |
Low: |
0.93 |
|
RSI |
RSI(14):
|
50.44 |
Change(%): |
579.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.200 |
Return on Equity (ttm) |
-29.1 |
Shares Out. (M) |
86.15 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-26.0 |
Shares Float (M) |
84.06 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
26.60 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4829 |
|
Book Value (p.s.) |
9.610 |
EBITDA (p.s.) |
-0.046 |
P/E |
-35.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.27 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.41 |
P/CF |
-59.81 |
|
|
|
|
|
|
